By Matthew Mahady
Advertisement
Articles by By Matthew Mahady
Advertisement
Latest Updated Articles
Fast Facts: New Cancer Survival DataPublished: June 29th 2010 | Updated:
Fast FactsPublished: June 23rd 2010 | Updated:
Fast Facts: Skin Cancer and MelanomaPublished: June 25th 2010 | Updated:
FDA Grants Priority Review to Potential Liver Cancer TherapyPublished: June 30th 2010 | Updated:
Pfizer Continues Transformation; Stakes Future on New DirectionPublished: May 24th 2010 | Updated:
Rapid Pace of Oncology Industry Consolidation Continues: Pfizer's Sights on Bayer, ImClone Runs from BMS to Eli LillyPublished: May 24th 2010 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
3
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
4
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
5
